IRIS Accounts Production v26.2.0.496 09923907 Board of Directors Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 09923907 2025-03-31 09923907 2026-03-31 09923907 2025-04-01 2026-03-31 09923907 2024-03-31 09923907 2024-04-01 2025-03-31 09923907 2025-03-31 09923907 ns15:EnglandWales 2025-04-01 2026-03-31 09923907 ns14:PoundSterling 2025-04-01 2026-03-31 09923907 ns10:Director1 2025-04-01 2026-03-31 09923907 ns10:Director2 2025-04-01 2026-03-31 09923907 ns10:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09923907 ns10:SmallEntities 2025-04-01 2026-03-31 09923907 ns10:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 09923907 ns10:SmallCompaniesRegimeForDirectorsReport 2025-04-01 2026-03-31 09923907 ns10:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09923907 ns10:FullAccounts 2025-04-01 2026-03-31 09923907 ns10:RegisteredOffice 2025-04-01 2026-03-31 09923907 ns5:CurrentFinancialInstruments 2026-03-31 09923907 ns5:CurrentFinancialInstruments 2025-03-31 09923907 ns5:Non-currentFinancialInstruments 2026-03-31 09923907 ns5:Non-currentFinancialInstruments 2025-03-31 09923907 ns5:ShareCapital 2026-03-31 09923907 ns5:ShareCapital 2025-03-31 09923907 ns5:RetainedEarningsAccumulatedLosses 2026-03-31 09923907 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 09923907 ns5:FurnitureFittings 2025-04-01 2026-03-31 09923907 ns5:ComputerEquipment 2025-04-01 2026-03-31 09923907 ns5:FurnitureFittings 2025-03-31 09923907 ns5:ComputerEquipment 2025-03-31 09923907 ns5:FurnitureFittings 2026-03-31 09923907 ns5:ComputerEquipment 2026-03-31 09923907 ns5:FurnitureFittings 2025-03-31 09923907 ns5:ComputerEquipment 2025-03-31 09923907 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-03-31 09923907 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 09923907 ns10:Director1 1 2025-03-31 09923907 ns10:Director1 1 2024-03-31 09923907 ns10:Director1 1 2025-04-01 2026-03-31 09923907 ns10:Director1 1 2024-04-01 2025-03-31 09923907 ns10:Director1 1 2026-03-31 09923907 ns10:Director1 1 2025-03-31 09923907 2 ns10:Director2 2025-03-31 09923907 2 ns10:Director2 2024-03-31 09923907 2 ns10:Director2 2025-04-01 2026-03-31 09923907 2 ns10:Director2 2024-04-01 2025-03-31 09923907 2 ns10:Director2 2026-03-31 09923907 2 ns10:Director2 2025-03-31

REGISTERED NUMBER: 09923907 (England and Wales)

CROSSROADS CLINIC LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2026

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| Chartered Accountants' Report | 8 |

| CROSSROADS CLINIC LTD |

COMPANY INFORMATION

FOR THE YEAR ENDED 31 MARCH 2026

| DIRECTORS: | Mrs S E Haycock

| Mrs E Protheroe

| REGISTERED OFFICE: | C/O Bevan Buckland Ltd

| Ground Floor

| Cardigan House

| Swansea

| SA7 9LA

| REGISTERED NUMBER: | 09923907 (England and Wales)

| ACCOUNTANTS: | Bevan Buckland Ltd

| Ground Floor Cardigan House

| Castle Court

| Swansea Enterprise Park

| Swansea

| SA7 9LA

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

BALANCE SHEET

31 MARCH 2026

| 2026 | 2025 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 852 |  | 1,238 |  |

CURRENT ASSETS

Debtors | 5 | 52,647 |  | 37,994 |  |

Cash at bank and in hand | 2,500 |  | 5,273 |  |

55,147 |  | 43,267 |  |

CREDITORS

Amounts falling due within one year | 6 | 47,318 |  | 44,943 |  |

NET CURRENT ASSETS/(LIABILITIES) | 7,829 |  | (1,676 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 8,681 |  | (438 | ) |

CREDITORS

Amounts falling due after more than one year | 7 | 8,284 |  | 10,896 |  |

NET ASSETS/(LIABILITIES) | 397 |  | (11,334 | ) |

CAPITAL AND RESERVES

Called up share capital | 100 |  | 100 |  |

Retained earnings | 297 |  | (11,434 | ) |

SHAREHOLDERS' FUNDS | 397 |  | (11,334 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

BALANCE SHEET - continued

31 MARCH 2026

The financial statements were approved by the Board of Directors and authorised for issue on 10 August 2026 and were signed on its behalf by:

Mrs S E Haycock - Director

Mrs E Protheroe - Director

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

1. | STATUTORY INFORMATION

| Crossroads Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 25% reducing balance

| Computer equipment | - | 33% - Straight Line

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

2. | ACCOUNTING POLICIES - continued

| Cash at bank and cash in hand

| Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

| Debtors

| Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

| Creditors and provisions

| Creditors and provisions are recognised where the company has a present obligation (legal and constructive) resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

| Financial Instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all its financial instruments.

| Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Basic financial assets

| Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

| Impairment of Financial Assets

| Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

| Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss

| If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

| Derecognition of financial assets

| Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

| Classification of Financial Liabilities

| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Basic financial liabilities

| Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

| Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

2. | ACCOUNTING POLICIES - continued

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

| Derecognition of financial liabilities

| Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 5 (2025 - 5 ) .

4. | TANGIBLE FIXED ASSETS

| Fixtures |

| and |  | Computer |

| fittings |  | equipment |  | Totals

£ | £ | £ |

| COST

| At 1 April 2025

| and 31 March 2026 | 5,888 |  | 1,378 |  | 7,266 |  |

| DEPRECIATION

| At 1 April 2025 | 5,146 |  | 882 |  | 6,028 |  |

| Charge for year | 186 |  | 200 |  | 386 |  |

| At 31 March 2026 | 5,332 |  | 1,082 |  | 6,414 |  |

| NET BOOK VALUE

| At 31 March 2026 | 556 |  | 296 |  | 852 |  |

| At 31 March 2025 | 742 |  | 496 |  | 1,238 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Other debtors | 52,647 |  | 37,994 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Bank loans and overdrafts | 3,092 |  | 3,054 |  |

| Taxation and social security | 10,857 |  | 9,264 |  |

| Other creditors | 33,369 |  | 32,625 |  |

47,318 |  | 44,943 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2026 | 2025 |

£ | £ |

| Bank loans | 8,284 |  | 10,896 |  |

| CROSSROADS CLINIC LTD (REGISTERED NUMBER: 09923907) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

8. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

2026 | 2025 |

£ | £ |

| Mrs S E Haycock

| Balance outstanding at start of year | 20,448 |  | 22,187 |  |

| Amounts advanced | 39,540 |  | 97,639 |  |

| Amounts repaid | (32,442 | ) | (99,378 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 27,546 |  | 20,448 |  |

| Mrs E Protheroe

| Balance outstanding at start of year | 17,417 |  | 22,180 |  |

| Amounts advanced | 40,093 |  | 94,615 |  |

| Amounts repaid | (32,442 | ) | (99,378 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 25,068 |  | 17,417 |  |

| Included in other debtors is an amount of £52,613 (2024: £37,865) which is owed by the directors. This amount will be repaid within nine months of the year end.

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS

ON THE UNAUDITED FINANCIAL STATEMENTS OF

CROSSROADS CLINIC LTD

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Crossroads Clinic Ltd for the year ended 31 March 2026 which comprise the Statement of Income and Retained Earnings, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Crossroads Clinic Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Crossroads Clinic Ltd and state those matters that we have agreed to state to the Board of Directors of Crossroads Clinic Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Crossroads Clinic Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Crossroads Clinic Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Crossroads Clinic Ltd. You consider that Crossroads Clinic Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Crossroads Clinic Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Bevan Buckland Ltd

Ground Floor Cardigan House

Castle Court

Swansea Enterprise Park

Swansea

SA7 9LA

10 August 2026